Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cotellessa, M.
Right arrow Articles by Lorini, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cotellessa, M.
Right arrow Articles by Lorini, R.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes Care 24:969-970, 2001
© 2001 by the American Diabetes Association, Inc.


Letters: Comments and Responses
Letter

Low Total Plasma Homocysteine Concentrations in Patients With Type 1 Diabetes

Mario Cotellessa, MD1, Giuseppe Minniti, MS1, Roberto Cerone, MD1, Francesca Prigione, MD1, Maria Grazia Calevo, MS2 and Renata Lorini, MD1

1 Department of Pediatrics
2 Service of Epidemiology and Biostatistics-Scientific Direction, University of Genoa, G. Gaslini Institute, Genoa, Italy

We read with great interest the recent article by C. Pavia et al. (1) on total homocysteine (tHcy) and its modifying vitamin factors (folates and vitamins B12 and B6) in adolescents with type 1 diabetes. The authors studied the possible relationship between hyperhomocysteinemia in type 1 diabetes and duration of disease, degree of metabolic control, presence of microalbuminuria, alterations in fundus oculi, and chronic lymphocytic thyroiditis.

Numerous studies clearly demonstrate that mild hyperhomocysteinemia is strongly related to vascular diseases (2,3). Patients with diabetes often develop premature vascular disease. In type 2 diabetes, increased plasma concentrations of tHcy were . . . [Full Text of this Article]

FOOTNOTES

References


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J Trop PediatrHome page
E. C. Dinleyici, B. Kirel, O. Alatas, H. Muslumanoglu, Z. Kilic, and N. Dogruel
Plasma Total Homocysteine Levels in Children with Type 1 Diabetes: Relationship with Vitamin Status, Methylene Tetrahydrofolate Reductase Genotype, Disease Parameters and Coronary Risk Factors
J Trop Pediatr, August 1, 2006; 52(4): 260 - 266.
[Abstract] [Full Text] [PDF]


Home page
British Journal of Diabetes & Vascular DiseaseHome page
F. Wotherspoon, D. W Laight, K. M Shaw, and M. H Cummings
Review: Homocysteine, endothelial dysfunction and oxidative stress in type 1 diabetes mellitus
The British Journal of Diabetes & Vascular Disease, September 1, 2003; 3(5): 334 - 340.
[Abstract] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A. L. Bjorke Monsen and P. M. Ueland
Homocysteine and methylmalonic acid in diagnosis and risk assessment from infancy to adolescence
Am. J. Clinical Nutrition, July 1, 2003; 78(1): 7 - 21.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
S. Brzosko, M. Mysliwiec, M. B. Donati, and L. Iacoviello
Homocysteinemia in Patients With Type 1 Diabetes in Relation to Renal Function
Diabetes Care, December 1, 2001; 24(12): 2158 - 2158.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2001 by the American Diabetes Association.